(Q41105921)

English

Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.

scientific article published on June 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

M Vadillo-Buenfil

8

object named as

M Vadillo-Buenfil

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

author name string

A Jungwirth

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

J Pinski

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

G Galvan

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

G Halmos

4

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

K Szepeshazi

5

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

R Z Cai

6

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

K Groot

7

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 1997

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1141-1148

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Screening for prostate cancer--necessity or nonsense?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen levels and clinical response to low dose dexamethasone for hormone-refractory metastatic prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatostatin receptors in human prostate and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation of a human prostate carcinoma cell line (DU 145)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions between epidermal growth factor-mediated autocrine regulation and linoleic acid-stimulated growth of a human prostate cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of bombesin/gastrin-releasing peptide receptors in membranes of MKN45 human gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

LH-RH analogue carrying a cytotoxic radical is internalized by rat pituitary cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Bombesin stimulates growth of human prostatic cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the pituitary-gonadal axis in nude male mice by continuous administration of LHRH agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory effects of the new bombesin receptor antagonist RC-3095 on the luteinizing hormone release in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900072-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(97)00072-5

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41105921&oldid=2119232232"